Heart closure devices market seen reaching $5.42 billion by 2030

The heart closure devices market is projected to grow from $3.08 billion in 2025 to $5.42 billion by 2030, driven by rising cardiovascular disease, minimally invasive procedures and broader adoption of catheter-based therapies. North America led the market in 2025, while Asia-Pacific is expected to grow fastest through the forecast period.

Why it matters: - Heart closure devices are used to seal abnormal openings in the heart, often through minimally invasive catheter procedures. - The technology reduces the need for open-heart surgery and can lower patient risk and recovery time. - Rising cardiovascular disease rates are increasing demand for treatments that address structural heart problems.

What happened: - The heart closure devices market is projected to rise from $3.08 billion in 2025 to $3.46 billion in 2026. - The market is forecast to reach $5.42 billion by 2030. - The forecast implies a 12.2% CAGR from 2025 to 2026 and an 11.9% CAGR through 2030. - The Business Research Company published the outlook on Aug. 10, 2026. - A free sample report is available. - The full market report is also available.

The details: - Heart closure devices treat atrial septal defects, patent foramen ovale and other structural heart abnormalities. - These devices are typically delivered through catheter-based, minimally invasive procedures. - Market growth has been supported by rising congenital heart defect cases, expansion of catheterization labs, increased use of minimally invasive cardiac treatments, greater awareness of structural heart disease and better imaging for procedure guidance. - Future growth drivers include demand for catheter-based therapies, more investment in structural heart disease treatment, expansion of specialized cardiac centers, efforts to reduce surgical risk and ongoing device innovation. - Key trends include wider adoption of transcatheter heart closure procedures, greater use of nitinol-based closure systems, expansion of structural heart intervention programs and more focus on procedural safety and efficacy. - Cardiovascular disease trends are also adding pressure on health systems to adopt less invasive options. - Singapore Heart Foundation data released in May 2024 showed cardiovascular disease caused 26,885 deaths in Singapore in 2023, including 5,302 deaths from ischemic heart disease, up from 5,290 in 2022.

Between the lines: - The forecast suggests structural heart care is moving toward procedures that can be done through catheters instead of surgery. - North America's lead reflects advanced healthcare infrastructure and high adoption of minimally invasive cardiac therapies. - Asia-Pacific is expected to be the fastest-growing region as access and treatment capacity expand. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The report package now includes market attractiveness scoring, total addressable market analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technology analysis and updated charts.

What's next: - Growth is expected to continue as hospitals expand structural heart programs and adopt newer closure systems. - The next wave of demand will likely come from centers that want safer, less invasive alternatives to surgery. - Regional gains in Asia-Pacific may narrow the gap with North America if investment and access continue to improve.

The bottom line: - Heart closure devices are moving from a niche structural heart tool to a faster-growing segment of the cardiovascular device market.